[1] Annunziato, M.A. (1997) Clinical, Mycotic, and Anorectal Immunohistochemically Findings in Patients with AIDS. University Hospital. Dr. Angel Larralde, University of Carabobo, Valencia, Venezuela. Department of Internal Medicine. Special Research to Qualify for the Title of Internal Medicine Specialist.
[2] Smith, P.D., et al. (1992) Gastrointestinal Infections in AIDS. Annals of Internal Medicine, 116, 63-77.
https://doi.org/10.7326/0003-4819-116-1-63
[3] Gold, J.W., Telzak, E.E. and White, D.A. (1996) Management of the HIV-Infected Patient, Part I. The Medical Clinics of North America, 80, 1223-1238, 1395-1414.
[4] Carvajal, A. (1997) Acquired Immunodeficiency Syndrome. In: Núñez, M.J. and Gómez, M.J., Eds., Medical Microbiology, 2 Edition, Vice-Rectorate Academic U.C.V, Venezuela, 885-913.
[5] Brar, H.S., et al. (1998) Anorectal Pathology in AIDS. Gastrointestinal Endoscopy Clinics of North America, 8, 913-931.
[6] Kent, C., Samuel, M. and Winskelstein, W.J.R. (1987) The Role of Anal/Genital Warts in HIV Infection. JAMA, 258, 3385-3386.
https://doi.org/10.1001/jama.1987.03400230045017
[7] Annunziato, M.A. (2000) Anorectal Findings in Patients Infected with HIV. University Hospital of Caracas, Central University of Venezuela, Caracas, Venezuela. Special Research to Qualify for the Title of Specialist on Infectious Diseases.
[8] Orkin, B.A. and Smith, L.E. (1992) Perianal Manifestations of HIV Infection. Diseases of the Colon & Rectum, 35, 310-314.
https://doi.org/10.1007/BF02048106
[9] Guadalupe, et al. (2003) Severe CD4+ t-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration Following Highly Active Antiretroviral Therapy. Journal of Virology, 80, 11708-11717.
https://doi.org/10.1128/JVI.77.21.11708-11717.2003
[10] Belmonte, L., et al. (2007) The Intestinal Mucosa as a Reservoir of HIV-1 after Successful HAART. AIDS, 21, 2106-2108.
https://doi.org/10.1097/QAD.0b013e3282efb74b
[11] Mariangela, C., et al. (2013) R5 HIV-1 Envelope Attracts Dendritic Cells to Cross the Human Intestinal Epithelium and Sample Luminal Virions via Engagement of the CCR5. EMBO Molecular Medicine, 5, 776-794.
https://doi.org/10.1002/emmm.201202232
[12] Veazey, R.S. and Lackner, A.A. (1998) The Gastrointestinal Tract and the Pathogenesis of AIDS. AIDS, 12, S35-S42.
[13] Scheider, T., Ullrich, R. and Zeitz, M. (1997) Immunopathology of Human Immunodeficiency Virus Infection in the Gatrointestinal Tract. Seminars in Immunopathology, 18, 515-533.
https://doi.org/10.1007/BF00824056
[14] Guadalupe, et al. (2006) Viral Suppression and Immune Restoration in the Gastrointestinal Mucosa of Human Immunodeficiency Virus Type 1-Infected Patients Initiating Therapy during Primary or Chronic Infection. Journal of Virology, 80, 8236-8247.
https://doi.org/10.1128/JVI.00120-06
[15] Sanjay, S., et al. (2004) P Glycoprotein in Human Immunodeficiency Virus Type 1 Infection and Therapy. Antimicrobial Agents and Chemotherapy, 48, 1073-1108.
https://doi.org/10.1128/AAC.48.4.1073-1081.2004
[16] Kotler, D.P. (1989) Intestinal and Hepatic Manifestations of AIDS. Advances in Internal Medicine, 34, 43-72.
[17] Greenson, J.K., Belitsos, P.C., Yardley, J.H., et al. (1991) AIDS Entheropathy: Occult Enteric Infections and Duodenal Mucosal Alterations in Chronic Diarrhea. Annals of Internal Medicine, 114, 366-372.
https://doi.org/10.7326/0003-4819-114-5-366
[18] Kottler, D.P., Reka, S. and Clayton, F. (1993) Intestinal Mucosal Inflamation Associated with Human Immunodeficiency Virus Infection. Digestive Diseases Sciences, 38, 1119-1127.
https://doi.org/10.1007/BF01295730
[19] Paiardini, M., et al. (2008) Mucosal Immune Dysfunction in AIDS Pathogenesis. AIDS Reviews, 10, 36-46.
[20] Fox, A., et al. (2005) The Value of Anal Cytology and Human Papillomavirus Typing in the Detection of Anal Intraepithelial Neoplasia: A Review of Cases from an Anoscopy Clinic. Sexually Transmitted Infections, 81, 142-146.
https://doi.org/10.1136/sti.2003.008318
[21] Piketty, C., et al. (2008) Marked Increase in the Incidence of Invasive anal Cancer among HIV-Infected Patients Despite Treatment with Combination Antiretroviral Therapy. AIDS, 19, 1203-1211.
[22] Palefky, J.M. (1999) Anal Squamos Intraepitelial: Relation to HIV and Human Papillomavirus Infection. Journal of AIDS, 21, S42-S48.
[23] Barbaro, G. and Barbarini, G. (2007) HIV Infection and Cancer in the Era of Highly Active Antiretroviral Therapy (Review). Oncology Reports, 17, 1121-1126.
https://www.ncbi.nlm.nih.gov/pubmed/17390054
[24] Pérez-Matute, P., et al. (2013) Role of Mitochondria in HIV Infection and Associated Metabolic Disorders: Focus on Nonalcoholic Fatty Liver Disease and Lipodystrophy Syndrome. Oxidative Medicine and Cellular Longevity, 2013, Article ID: 493413.
https://www.hindawi.com/journals/omcl/2013/493413/
[25] Mergia, A. (2017) The Role of Caveolin 1 in HIV Infection and Pathogenesis. Viruses, 9, 129.
http://www.mdpi.com/1999-4915/9/6/129
https://doi.org/10.3390/v9060129
[26] Benson, E.J., et al. (2014) Development of HIV Reservoir Targeted Long Acting Nanoformulated Antiretroviral Therapies. Current Medicinal Chemistry, 21, 4186-4198.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281174/
https://doi.org/10.2174/0929867321666140826114135
[27] Corsi, F., et al. (2016) Antiretroviral Therapy through Barriers: A Prominent Role for Nanotechnology in HIV-1 Eradication from Sanctuaries. Journal of Pharmacy and Pharmacology, 4, 328-339.
https://air.unimi.it/retrieve/handle/2434/526744/911463/7-JPP2016021701.pdf
[28] Wang, Z., et al. (2011) Targeting of Nanoparticle-Complexed Drugs across the Vascular Endothelial Barrier via Caveolae. IUBMB Life, 63, 659-667.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142311/
https://doi.org/10.1002/iub.485
[29] Beloqui, A., et al. (2013) Mechanism of Transport of Saquinavir-Loaded Nanostructured Lipid Carriers across the Intestinal Barrier. Journal of Controlled Release, 166, 115-123.
https://doi.org/10.1016/j.jconrel.2012.12.021
https://cdn.uclouvain.be/public/Exports%20reddot/ir-ldri/images/Beloqui2013.pdf